6:14 PM
 | 
Apr 26, 2016
 |  BC Extra  |  Financial News

Allied Minds creates funding vehicle for BMS JV

The newly formed ABLS Capital subsidiary of Allied Minds plc (LSE:ALM) has secured commitments of up to $80 million to fund programs in Allied Minds' joint venture with Bristol-Myers Squibb Co. (NYSE:BMY). The funds will support lead optimization for up to 10 programs that have passed initial feasibility studies. BMS will provide up to $20 million more to fund the programs' lead optimization.

Investors in ABLS Capital include Woodford Investment Management, which is contributing up...

Read the full 370 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >